The global cannabidiol market size is estimated to increase from USD 8.52 billion in 2024 to reach USD 41.42 billion by 2035, representing a CAGR of 15.46% during the forecast period. According to the recent report of Centers for Disease Control and Prevention, close to 129 million people in United States are suffering from at least one chronic condition. Such patients require prolonged medication for the management of disease conditions and associated pain. Notably, there is a rapid increase in...

The global synthetic biology market is projected to grow from USD 23.88 billion in 2025 to USD 130.67 billion by 2035, representing a compounded annual growth rate of 18.53% during the forecast period. It is important to note here that Genomatica has achieved success in the development of microorganism-based production process (Geno proprietary technology) that converts renewable carbon of sugar plants into precursor to nylon (100% renewable carbon-based nylon-6). Furthermore, top fashion brands...

The global agricultural pheromones market is estimated to grow from USD 4.9 billion in 2024 to USD 15.3 billion by 2032. The market is projected to grow at a higher CAGR value of 15.3% during the forecast period. The global agricultural pheromones market is segmented into sex pheromones, aggregation pheromones, repellent pheromones, and others. According to our market study analysis, Sex pheromones account for the largest share, capturing 86% of the overall revenue share of the market in 2024. T...

The modular pharmaceutical construction market is likely to grow from USD 2.5 billion in 2024 to reach USD 2.8 billion in 2025 and USD 7.7 billion by 2035, representing a higher CAGR of 10.7% during the forecast period from 2025 to 2035. In terms of type of modular construction, the relocatable segment holds the highest share (close to 60%) of the market. With regards to size of facility, the very large segment dominates the global market with close to 40% market share. In terms of type of modu...

The global proteomics market, valued at USD 35.7 billion in 2025, is projected to reach USD 40.2 billion in 2026 and USD 94.7 billion by 2035, with a 10.0% CAGR during the forecast period 2026 to 2035. In terms of type of offering, the kits and reagents segment holds the highest share (75%) of the market. With regards to type of instrument / technology, the spectrometry segment dominates the global market with close to 30% market share. In terms of types of proteomics service, the core proteo...

The diabetes care devices market size is projected to grow from USD 39.82 billion in 2025 to USD 99.81 billion by 2035, representing a CAGR of 9.62% during the forecast period till 2035. Over the course of decades, the diabetes care device market has reached new heights of expansion driven by the growing number of diabetic patients worldwide. According to a report, approximately 800 million people have diabetes around the world. Diabetes rates in adults doubled from about 7% to 14% between 1990...

The global biotechnology market size is valued at 1.57 trillion in 2024 and is poised to reach USD 8.01 trillion by 2035, representing a CAGR of 15.98% during the forecast period. The increasing foothold of advanced drug formulation and personalized medicine are opening new opportunities for biotechnology companies to make investments for driving innovations. It is worth noting here that as of March 2022, The World Health Organization reported that around 11 billion doses of COVID-19 vaccines ha...

The global e-prescribing market, valued at USD 3.43 billion in 2024, is estimated to grow to USD 4.51 billion in 2025 and USD 36.62 billion by 2035, representing a CAGR of 23.3% during the forecast period. As per a research study published in 2024, prescribing errors accounted for 54% medication errors. These manual prescription errors can cause potential damage to patient health and lead to severe consequences. With e-Prescribing model, another research study predicted that there is a signific...

The cognitive assessment and training in healthcare market is estimated to grow from USD 6.44 billion in 2025 to USD 39.41 billion by 2035, representing a CAGR of 19.9% during the forecast period. A recent report published by the World Health Organization (WHO) highlighted that in 2023, over 55 million people suffered from dementia and around 10 million new cases are reported annually. Such rapid increase in dementia cases has necessitated the demand for advanced cognitive assessment instruments...

The global biopolymers market, valued at USD 9.31 billion in 2024, is projected to reach USD 11.08 billion in 2025 and USD 62.88 billion by 2035, representing a CAGR of 18.96% during the forecast period. Currently, the starch-based polymers accounts for the highest share (35%) of the market. Among these end users, currently packaging accounts for the highest biopolymers market share (57%). Europe holds the highest share (39%) of the market owing to the rising demand for biodegradable and sustain...

The global wearable medical devices market is valued at USD 39.31 billion in 2025 and is estimated to reach USD 232.98 billion by 2035, representing a CAGR of 19.48% during the forecast period. In August 2024, Re-Time launched retimer 3, a smart sleep wearable, to support the people dealing with poor circadian rhythms. In the same month, HUAWEI launched HUAWEI TruSense system, a digital health and fitness sensor technology, that will support continuous vital monitoring. Examples of key players e...

The global flow cytometry market size is valued at USD 5.1 billion in 2024 and is poised to reach USD 10.75 billion in 2032, representing a CAGR of 8.25% during the forecast period. Based on the type of product, the market for flow cytometry is split into reagents and consumables, flow cytometry instruments, accessories, flow cytometry services, and software. Reagents and consumables are expected to dominate the segment with more than 54% of the total flow cytometry market share in 2024. The adv...

The global bioprocess containers market size is estimated to grow from USD 4.73 billion in 2025 to USD 32.10 billion by 2035, representing a compounded annual growth rate (CAGR) of 21.1% during the forecast period. It is important to highlight here that in April 2022, Thermo Fisher Scientific opened its 55,000 sq. feet single-use technology facility in Ogden which is dedicated to single-use bioprocess containers. This single-use technology facility in Ogden is worth USD 44 million and is a part...

The global next generation sequencing services market is estimated to reach USD 12.2 billion in 2025, increasing to USD 87.5 billion by 2035, representing a CAGR of 21.78% during the forecast period. North America maintains a well-established technology manufacturers network and supportive regulatory guidelines for using genetic tests. Additionally, the advanced healthcare infrastructure and rising focus on oncology precision medicine is another significant driver of the next generation sequenci...

Digital psychotherapeutics market is estimated to be USD 2.14 billion in 2025 and is poised to reach USD 25.71 billion by 2035, representing a CAGR of 28.2% during the forecast period. According to a recent report published by the American Psychiatric Association, in 2024, nearly 43% of the adult population is suffering from anxiety. Moreover, the World Health Organization reported that around 280 million people across the globe have depression and over 700,000 people annually die due to severe...

The medical terminology software market size is projected to grow from USD 1.33 billion in 2025 to USD 5.45 billion by 2035, representing a CAGR of 15.19% during the forecast period till 2035. In recent years, the growing number of deaths due to clinical errors has increased the importance of medical terminology software. According to an NIH report, medical errors are the third leading cause of death in the US which causes more than 200,000 deaths annually. These errors also impose a heavy finan...

The global regenerative medicine market is valued at USD 13.8 billion in 2024 and is poised to reach USD 57.0 billion by 2035. It is expected to expand at a higher CAGR of ~14% during the forecast period. This promising field is receiving support from various industrial and government organizations to identify the potential of regenerative medicine beyond tissue repair. For instance, in March 2024, Pandorum Technologies (an India-based Biotechnology Company) announced securing USD 11 million dur...

Patient flow management solutions market is valued at USD 2.04 billion in 2025 and is poised to reach USD 13.88 billion by 2035, representing a CAGR of 21.1% during the forecast period. Currently, the real-time locating system segment dominates the market, accounting for 55% of the overall revenue share. Among the components, currently software accounts for the highest share (65%) of the market and this segment is likely to remain dominant during the forecast period. In April 2024, ABOUT Healthc...

The global orphan drug market size is expected to grow from USD 236.27 billion in 2025 to reach USD 667.48 billion by 2035, representing a CAGR of 10.94% over the forecast period. With rising risk of rare diseases and some rare oncological disorders, the demand for orphan drugs has significantly increased to treat patients. A recent report published by National Center for Advancing Translational Sciences highlighted that nearly 10,000 rare diseases affect the US population. Moreover, according t...

The global in vitro diagnostics market, valued at USD 113 billion in 2025, is projected to reach USD 118 billion in 2026 and USD 190 billion by 2035, with a 5.4% CAGR during the forecast period 2026 to 2035. The laboratory segment holds the highest share (~85%) of the market. With regards to type of offering, the reagents segment dominates the global market with 75% of the market share. Based on the type of technology, the immunoassay segment holds the largest market share (nearly 35%) in 202...